EURneffy Frequently Asked Questions

Allergy UK has produced this Frequently Asked Questions (FAQ) document to help provide clear and reliable information about EURneffy, a new adrenaline administration device for the treatment of anaphylaxis. EURneffy represents an important advancement in allergy management, as it offers a needle-free nasal spray alternative to traditional adrenaline auto-injectors (AAIs). It is designed for rapid absorption through the nasal lining, providing a fast and effective way to deliver adrenaline during a severe allergic reaction.

This resource has been developed to support people living with allergic disease, as well as their families, carers, and schools, by addressing common questions about how EURneffy works, who it is suitable for, and how it should be used and stored. Whether you are newly prescribed EURneffy or simply want to understand more about this innovative treatment option, the following FAQs aim to give you the information and reassurance you need.

If you have any concerns about your medication or its suitability for you or your child, please speak to your GP, allergy specialist, or pharmacist.